Traws Pharma, Inc. (TRAW) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Traws Pharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 1.01x | -0.25x | -0.83x | -0.72x | -2.66x | -3.25x |
| P/B Ratio | -14.78x | -0.44x | 1.48x | 0.48x | 0.93x | 13.25x |
| P/S Ratio | 3.33x | 61.01x | 69.65x | 60.13x | 189.92x | 354.10x |
| Profitability | ||||||
| Gross Margin | 100.0% | 94.7% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -640.7% | -21835.4% | -8981.4% | -8684.5% | -7299.1% | -10819.5% |
| Net Margin | 328.7% | -24192.0% | -8384.1% | -8391.2% | -7151.8% | -10890.5% |
| EBITDA Margin | -638.5% | -73677.4% | -8974.3% | -8678.3% | -7292.9% | -10813.9% |
| Liquidity | ||||||
| Current Ratio | 0.72x | 2.16x | 2.46x | 4.89x | 9.06x | 1.97x |
| Quick Ratio | 0.72x | 2.16x | 2.46x | 4.89x | 9.06x | 1.92x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..